Key result
Angiotensinogen gene M235T (p=0.0015) and G(-6)A (p=0.029) polymorphisms, along with elevated plasma angiotensinogen (p<0.0001), were significantly associated with isolated systolic hypertension.
Why the study?
Are angiotensinogen gene polymorphisms and expression levels associated with isolated systolic hypertension?
Case-Control (n=206)
Are angiotensinogen gene polymorphisms and expression levels associated with isolated systolic hypertension?
p-value: p=0.0015
Angiotensinogen gene variants and elevated plasma angiotensinogen concentrations are associated with isolated systolic hypertension, suggesting a genetic role in its etiology.
Angiotensinogen variants may contribute to isolated systolic hypertension risk; hypothesis-generating and should not yet change practice.
Isolated systolic hypertension (ISH) occurs predominantly in the elderly, with a considerable morbidity and mortality. Its etiology is unknown but is likely to involve a significant genetic component. The aim of this study was to examine the angiotensinogen gene in ISH. The M235T and G(- 6)A polymorphisms were genotyped by polymerase chain reaction (PCR) in 86 ISH patients and 120 normotensive controls. Plasma angiotensinogen concentration was determined in 198 subjects by an indirect radioimmunoassay technique. Angiotensinogen mRNA concentration was determined by quantitative competitive reverse transcription (RT)-PCR in subcutaneous adipose tissue from a subset of these patients (n = 8) and controls (n = 6). Both the M235T (p = 0.0015) and G(- 6)A (p = 0.029) polymorphisms were associated with ISH. Plasma angiotensinogen concentration was higher in patients than controls (p < 0.0001), but was not associated with genotype. Angiotensinogen mRNA concentration in adipose tissue from ISH subjects was significantly lower than in adipose tissue from normotensive subjects (p = 0.033). The association of angiotensinogen gene variants with ISH and the elevation of plasma angiotensinogen concentration in these patients suggests a role of the angiotensinogen gene in this form of hypertension. Angiotensinogen gene expression may be altered in ISH, but this requires further examination.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2002) conducted a case-control in Isolated systolic hypertension (ISH) (n=206). Angiotensinogen gene M235T and G(- 6)A polymorphisms vs. Normotensive controls was evaluated on Association of M235T and G(- 6)A polymorphisms with ISH (p=0.0015). Angiotensinogen gene M235T (p=0.0015) and G(-6)A (p=0.029) polymorphisms, along with elevated plasma angiotensinogen (p<0.0001), were significantly associated with isolated systolic hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: